Click Holdings Limited (NASDAQ:CLIK) Short Interest Up 490.1% in January

Click Holdings Limited (NASDAQ:CLIK) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totaling 3,446 shares, an increase of 490.1% from the December 31st total of 584 shares. Based on an average daily volume of 9,700 shares, the short-interest ratio is presently 0.4 days. Currently, 0.3% of the company’s shares are short sold. Currently, 0.3% of the company’s shares are short sold. Based on an average daily volume of 9,700 shares, the short-interest ratio is presently 0.4 days.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Click in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

Click Trading Up 4.9%

CLIK stock opened at $4.93 on Wednesday. The business’s 50-day moving average price is $5.60 and its two-hundred day moving average price is $7.93. Click has a 1-year low of $4.32 and a 1-year high of $102.90.

Click Company Profile

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.